跳至主要内容
临床试验/NCT01505257
NCT01505257已完成不适用

Early Nurse Detection of Delirium Superimposed on Dementia

Penn State University3 个研究点 分布在 1 个国家目标入组 391 人开始时间: 2010年4月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
391
试验地点
3
主要终点
Inappropriate CNS-Active Medication Use

研究概览

简要总结

Delirium (acute confusion) is common and costly in persons with dementia, resulting in longer hospital stays, more complications, and greater functional decline. This research tests the use of the electronic health record, education, and regular feedback to nurses to improve detection and management of delirium. Ultimately, findings will direct ways to improve acute care of this vulnerable population.

详细描述

Delirium is an acute, reversible change in mental status that occurs in over 40% of persons with dementia. Delirium superimposed on dementia (DSD) leads to increased mortality, increased costs, nursing home placement, early re-hospitalization, and functional decline. Delirium in persons with dementia appears to substantially worsen outcomes in persons with dementia- who are already burdened with functional decline. The purpose of this study is to improve nursing detection and management of delirium in persons with dementia and decrease the duration and patient complications of delirium. To achieve these objectives, a multi-component intervention strategy called, Early Nurse Detection of Delirium Superimposed on Dementia (END DSD) will be tested. END-DSD employs a paired cluster randomized trial (C-RCT) of three hospitals with a total of six inpatient units and 360 hospitalized persons with dementia to achieve these objectives. END DSD intervention consists of 1) Nursing education regarding DSD, 2) Computerized decision support through standardized delirium assessment and management screens via the electronic health record (EHR), 3) an identified unit champion on each intervention unit who will be utilized to persuade other nurses to implement the innovation, and 4) Weekly feedback to the nursing staff to further facilitate assessment and management of delirium. We are testing the following specific aims: A.1: To determine whether the intervention "END DSD" improves nurse detection and management of DSD. A.2: To determine the effect of "END DSD" intervention on patient clinical outcomes, including duration of delirium and rate of psychoactive medications.

The study focuses on a costly and prevalent problem, and utilizes a novel approach that via the EHR will clearly be replicable across settings of care. END-DSD has the potential to significantly improve quality of life and decrease costs of care by: improving the detection of DSD; increasing the use of non-pharmacological management of DSD; shortening the duration of delirium and hospital length of stay; and decreasing the use of inappropriate medications, thus mitigating the complications of DSD. This project builds on over a decade of funded research and clinical practice by the investigators, and brings their unique and collaborative efforts together in an innovative manner to impact the under addressed problem of DSD in hospitalized older adults.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Persons with dementia will be included if they: a) are on one of the selected medical-surgical units and are age 65 years or older; b) have been hospitalized less than 48 hours; and c) meet the criteria for dementia. The study will include minorities and women.

排除标准

  • Persons with dementia will be excluded if they have any significant neurological or neurosurgical disease associated with cognitive impairment other than dementia (due to confounding with dementia or DSD), such as:
  • Lewy Body Dementia
  • Huntington's disease
  • Sormal pressure hydrocephalus
  • Seizure disorder
  • Subdural hematoma
  • Head trauma
  • Known structural brain abnormalities
  • Nonverbal and unable to communicate due to severe dementia (MMSE=0)
  • Intubation
  • Terminal illness (since interviews are required for the study).
  • This study will not exclude persons with pre-existing delirium.
  • In addition, subjects will not be excluded on the basis of race or gender.

研究组 & 干预措施

END-DSD Intervention

Experimental

干预措施: END-DSD (Behavioral)

Control

No Intervention

结局指标

主要结局

Inappropriate CNS-Active Medication Use

时间窗: Participants will be assessed daily until discharge (duration of hospitalization), which is expected to be about 5 days

Ascertained from patient's medical record

Severity of Delirium

时间窗: Participants will be assessed daily until discharge (duration of hospitalization), which is expected to be about 5 days

Measured using the Delirium Rating Scale R-98.

Delirium Duration

时间窗: Participants will be assessed daily until discharge (duration of hospitalization), which is expected to be about 5 days

Measured using the Confusion Assessment Method (CAM)

Nurse Detection of Delirium

时间窗: Participants will be assessed every shift until discharge (duration of hospitalization), which is expected to be about 5 days

Ascertained through electronic health record and chart review

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Donna Fick

PhD, RN, FGSA, FAAN

Penn State University

研究点 (3)

Loading locations...

相似试验